SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,598.67 -8.08
( -0.01%)

Global Indices

Nasdaq

52,379.88 143.72
(0.28%)

Dow Jones

7,698.05 53.37
(0.70%)

Hang Seng

63,411.54 1,221.89
(1.96%)

Nikkei 225

10,685.39 -81.94
(-0.76%)

Forex

USD-INR

94.93 0.33
(0.34%)

EUR-INR

106.36 0.18
(0.17%)

GBP-INR

126.93 0.23
(0.18%)

JPY-INR

0.61 0.00
(0.53%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

17.8742423

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

43.34

27.37

EPS(TTM)

Face Value()

Div & Yield %

0.44

Back

Salem Erode Investments reports standalone net loss of Rs 1.31 crore in the June 2026 quarter

Aug 14,2026

Net Loss of Salem Erode Investments reported to Rs 1.31 crore in the quarter ended June 2026 as against net loss of Rs 0.99 crore during the previous quarter ended June 2025. Sales declined 18.35% to Rs 0.89 crore in the quarter ended June 2026 as against Rs 1.09 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.89	1.09	-18
OPM %	-65.17	-23.85	-
PBDT	-1.00	-0.68	-47
PBT	-1.26	-0.99	-27
NP	-1.31	-0.99	-32

73,598.67 -8.08 ( -0.01%)

52,379.88 143.72 (0.28%)

7,698.05 53.37 (0.70%)

63,411.54 1,221.89 (1.96%)

10,685.39 -81.94 (-0.76%)

94.93 0.33 (0.34%)

106.36 0.18 (0.17%)

126.93 0.23 (0.18%)

0.61 0.00 (0.53%)